Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Integrator complex subunit 4-like 2 pseudogene" (ENSG00000260900) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but generally considered non-functional due to mutations or lack of regulatory elements necessary for proper expression[4][6][8]. Pseudogenes do not code for functional proteins and are usually remnants of genes that have lost their protein-coding or regulatory capacity through evolutionary processes[4][6]. While some pseudogenes can be transcribed or exert regulatory effects, most are not considered direct targets for therapeutic intervention, and there is no evidence that "Integrator complex subunit 4-like 2 pseudogene" encodes for an active molecule or participates in the molecular processes attributed to the functional Integrator complex[4][6][2]. Because of this, it is not considered a receptor, enzyme, transporter, or any canonical therapeutic target class, and is generally of interest for genomics research or bioinformatics classifications, not drug targeting or clinical relevance[2][4][6]. Additional Notes: - The presence of "pseudogene" in the name and genomic databases signals that this entity is not a protein-coding gene and does not encode an active version of Integrator complex subunit 4 or participate in the Integrator complex's biological functions[4][6][8]. - Such pseudogenes may be included in gene databases (including Ensembl, GeneCards), but their annotation highlights their non-functional nature and distinguishes them from bona fide protein-coding targets[4][3][6]. Summary of error/incorrectness: This is not a druggable target or functional biomolecule, but rather a pseudogene—a non-functional gene copy—meaning it should not be used in contexts where an active target (such as receptor, enzyme, transporter, etc.) is required[4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrator complex subunit 4-like 2 pseudogene.